Dark

ABBV
ABBVIE INC.
stock NYSE

At Close

Jul 8, 2026 3:59:58 PM EDT

252.68USD-0.774%(-1.97)5,673,823

240.74Bid 268.80Ask 28.06Spread

Pre-market

Jul 8, 2026 9:16:30 AM EDT

255.04USD+0.153%(+0.39)2,019

After-hours

Jul 8, 2026 4:12:30 PM EDT

252.00USD-0.269%(-0.68)1,768,006

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

446.38B

CEO

Richard Gonzalez

Headquarters

North Chicago, Illinois, USA

Industry

Drug Manufacturers-General

Next Earnings

Jul 31, 2026 (23d)

Last Dividend

Apr 15, 20251.640

AMGN NBIX GILD BIIB AZN GSK BMY LLY PFE XLV

ABBV Stats

Avg. Vol. 10 Day

12,527,522

Avg. Vol. 30 Day

8,021,023

Employees

30,000

Market Cap

446,380,206,226

Shares Out.

1,766,792,821

On/Off Exchange

53%/47%

6 Month Beta

-0.02

1 Year Beta

0.00

2 Year Beta

0.28

3 Year Beta

0.29

52 Week Low

184.63

52 Week High

261.64

SMA50

220.78

SMA200

222.37

1 Week

+0.63%

1 Month

+13.26%

3 Month

+19.41%

6 Month

+12.73%

1 Year

+33.14%

2 Year

+51.72%

5 Year

+117.15%

Profile

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.

ABBV Stock Summary

ABBVIE INC. (NYSE:ABBV) stock price today is $252.68, and today's volume is 5,673,823. ABBV is down -0.774% today. The 30 day average volume is 8,021,023. ABBV market cap is 446.38B with 1,766,792,821 shares outstanding.

document.getElementById("cNlFZs").onerror = function(){this.style.display='none';}; .dark-mode .mbL04k{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .mbL04k{ color: #333333; background-color: white; border: 2px solid #333333; }ABBVABBVIE INC.stock NYSE

ABBV Stock Summary

ABBV
ABBVIE INC.
stock NYSE